Nextech Invest Ltd is a private equity and venture capital firm in Switzerland that focuses on precision therapies in oncology. Founded 1998 in Zurich, Switzerland, it invests in early stage ventures, series B, series C, post-IPO equity, and series E rounds. Its portfolio companies include Circle Pharma, Silverback Therapeutics, Kinnate Biopharma, PMV Pharmaceuticals, and A2 Biotherapeutics. As of April 2020, Nextech Invest has made 33 investments. Their most recent investment was on March 17, 2020, when Circle Pharma raised $45M. Nextech Invest has had 17 exits, the most notable of which include Arvinas, Blueprint Medicines, and IDEAYA Biosciences. The company has raised a single venture fund, Oncology Fund IV. This fund was announced on July 21, 2016 and raised a total of $64M.
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases
Neon Therapeutics is a biotechnology company developing immunotherapies for treating cancer.
ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.
A company focused on the discovery and development of small molecule drugs for the treatment of diseases
A company focused on the development of personalized cancer therapies
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
Black Diamond Therapeutics is a Biotechnology company.
Kronos Bio is a Cambridge, Massachusetts-based company.
REVOLUTION Medicines is a Redwood City, California-based company.
Documentaries, videos and podcasts